erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Maxillofacial Injuries D008446 1 associated lipids
Dacryocystitis D003607 1 associated lipids
Erythrasma D004894 1 associated lipids
Granuloma, Respiratory Tract D015769 1 associated lipids
Pilonidal Sinus D010864 1 associated lipids
Postoperative Nausea and Vomiting D020250 1 associated lipids
Vagus Nerve Injuries D061223 1 associated lipids
Focal Infection, Dental D005491 1 associated lipids
Lymphoma, B-Cell, Marginal Zone D018442 1 associated lipids
Sialadenitis D012793 1 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
DENISENKO VA [Effecicacy of the peroral use of erythromycin in pyoderma]. 1962 Vestn Dermatol Venerol pmid:14026998
DI CARLO R and DE MARINIA E [Pharmacological research on a new water-soluble salt of erythromycin]. 1962 Chemotherapia (Basel) pmid:14027517
DITTLER EL Upper abdominal pain and intrahepatic cholestasis as manifestations of sensitivity to ilosone. 1962 Am. J. Gastroenterol. pmid:14028076
KOYA G et al. [Analysis of 54 cases of septicemia]. 1962 Jpn. J. Infect. Dis. pmid:14035265
REED C and RITCHIE F Toxic jaundice due to propionyl erythromycin ester lauryl sulphate ("Ilosone"). 1962 Med. J. Aust. pmid:14037477
RILEY WA Hepatitis following administration of Ilosome. Case report. 1962 N C Med J pmid:14038696
KATO Y et al. [Studies on propionyl erythromycin lauryl sulfate (PELS)]. 1962 J Antibiot B pmid:14042115
WILLCOX RR Treatment of early venereal syphilis with antibiotics. 1962 Br J Vener Dis pmid:14000784
WILLIAMSON GM and ZINNEMANN K The susceptibility of coliform bacilli to erythromycin. 1962 Antibiot Chemother (Northfield) pmid:14007243
YAMAMOTO C and KISHIMOTO K [Therapeutic results with ilotycin in refractory cases of syphilis]. 1962 Chiryo pmid:14008824
ISHIGAMI J et al. Studies on the prevention of infection by the addition of various bacteriocidal agents to the urographic media. 1962 Bull Osaka Med Sch pmid:13956825
JIJAKLI-SOMVILLE J [Pemphigus vegetans of the buccal, pharyngeal and laryngeal mucosa]. 1962 Arch Belg Dermatol Syphiligr pmid:13957748
BASS TM [On the problem of the inhibition of the development of resistance to erythromycin in staphylococci]. 1962 Antibiotiki pmid:13969871
POMINI P and TARTAGLIA G [On the therapeutic efficacy of a combination of demethylchlortetracycline with erythromycin laurylsulfate in obstetrics and gynecology]. 1962 Quad Clin Ostet Ginecol pmid:13972087
PALESI S and LAZZARI R [The combination of the laurylsulfate of erythromycin propionate and demethylchlortetracycline in the treatment of various infectious processes in infants]. 1962 Clin Pediatr (Bologna) pmid:13941194
PATTEE PA and BALDWIN JN Transduction of resistance to some macrolide antibiotics in Staphylococcus aureus. 1962 J. Bacteriol. pmid:13941896
DOLEZALOWA M and ZASOWSKI A [Sensitivity of Staphylococcus aureus in vitro to erythromycin, oleandomycin triacetate and novobiocin in suppurative surgical diseases]. 1962 Pol Przegl Chir pmid:13887010
EIDUS L et al. The affinity for monkey tissue of five antibiotics having erythromycin-like spectra. 1962 Chemotherapia (Basel) pmid:13889602
ROBINSON MM Demonstration by "challenge" of hepatic dysfunction associated with propionyl erythromycin ester lauryl sulfate. 1962 Antibiot Chemother (Northfield) pmid:14492925
ROBINSON MM Hepatic dysfunction associated with triacetyloleandomycin and propionyl erythromycin ester lauryl sulfate. 1962 Am. J. Med. Sci. pmid:14492926
GREGL A and MARGGRAF W [Studies on erycinum therapy in surgical diseases. Resistance tests and concentration determinations in different body fluids]. 1962 Munch Med Wochenschr pmid:13901614
GRIFFITH RS and BLACK HR A comparison of blood levels after oral administration of erythromycin and erythromycin estolate. 1962 Antibiot Chemother (Northfield) pmid:13901859
SAEVICH NA [Erythromycin and its use in infants with pneumonia]. 1962 Zdravookhr Beloruss pmid:14495964
GRIFFITH RS and BLACK HR Comparison of antimicrobial activity of erythromycin estolate and demethylchlortetracycline against hemolytic streptococci. 1962 Antibiot Chemother (Northfield) pmid:13901860
GROGAN JB et al. Antibiotic susceptibility of phage type 80/81 strains of staphylococci isolated from hospital and community populations. 1962 Antibiot Chemother (Northfield) pmid:13902091
BOURICHON J [Importance of the suppository form in the administration of propionyl-erythromycin to children]. 1962 Alger Medicale pmid:13871918
KANEDA T et al. Actinomycete antibiotics. III. The biogenesis of erythronolide, the C-21 branched chain lactone in erythromycin. 1962 J. Biol. Chem. pmid:14453579
WEISS E and DRESSLER HR Increased resistance to chloramphenicol in Rickettsia prowazekii with a note on failure to demonstrate genetic interaction among. 1962 J. Bacteriol. pmid:14040210
MIELE E et al. [Experimental research on the antibacterial activity and absorption of erythromycin propionate laurylsulfate and demethylchlortetracycline alone or in combination]. 1962 Jul-Aug Nuovi Ann Ig Microbiol pmid:13935631
GRUPPER C and GROSS A [Pseudo-epitheliomatous keratosic and ulcerous balanitis]. 1962 Jun-Jul Bull Soc Fr Dermatol Syphiligr pmid:13950953
BRETON A et al. [Clinical trial of a combination of propiocine and trisulfazine]. 1962 Jun-Jul Lille Med pmid:13872912
COPPI F [On the use of demethylchloretracycline alone or in association with erythromycin in urinary tract infections]. 1962 May-Jun Minerva Urol pmid:14022910
CUTILLO S and ROMAGNOLI A [Clinical trials of the combination of laurylsulfate of erythromycin propionate and demethylchlortetracycline]. 1962 Sep-Oct Pediatria (Napoli) pmid:14024398
KETYI I and BARNA K Effect of antibiotics on the aerobic intestinal flora of adults. 1962-1963 Acta Microbiol Acad Sci Hung pmid:14032203
TARIZZO ML and NABLI B [STUDIES ON TRACHOMA. 7. COMPARISON OF THE ACTION OF ANTIBIOTICS ON VARIOUS VIRUSES OF THE TRACHOMA GROUP IN EMBRYONATED EGG CULTURES]. 1963 Bull. World Health Organ. pmid:14058223
VYMOLA F and HEJZLAR M [ON THE PROBLEM OF DETERMINATION OF BACTERIAL SENSITIVITY TO ANTIBIOTICS IN VITRO]. 1963 Rozhl Chir pmid:14058700
SCHUBART AF et al. EFFECT OF PENICILLIN TREATMENT ON SERUM COMPLEMENT LEVELS IN ACUTE RHEUMATIC FEVER. 1963 Ann. Rheum. Dis. pmid:14059292
SCIARRA G and HEBOYAN M [ANTIBIOGRAMS IN PRESENCE OF TESTOSTERONE]. 1963 Arch Ital Sci Med Trop Parassitol pmid:14059327
NEGRO RC and GENTILE-RAMOS I [COMPLICATIONS CAUSED BY SULFONAMIDES AND ANTIBIOTICS]. 1963 Arch Pediatr Urug pmid:14043661
EBRINGER L [APOCHLOROSIS OF CELLS OF EUGLENA GRACILIS INDUCED WITH ERYTHROMYCIN]. 1963 Biologia pmid:14044842
ARAKI Y [STUDIES ON STAPHYLOCOCCOSIS IN CHILDHOOD]. 1963 Kumamoto Igakkai Zasshi pmid:14044996
SAITO M [CLINICAL FINDINGS OF BACTERIAL FOOD POISONING CAUXED BY VIBRIO PARAHAEMOLYTICUS]. 1963 Showa Igakkai Zasshi pmid:14157123
MARCOS P et al. [STUDIES ABOUT DECARBOXYLATING ENZYMES. XX. EFFECT OF SOME ANTIBIOTICS OF THERAPEUTIC USE ON L-GLUTAMATE CARBOXYLASE]. 1963 An Real Acad Farm pmid:14113462
GUAGLIANONE A et al. [PULMONARY STAPHYLOCOCCIA. BACTERIOLOGICAL, EPIDEMIOLOGICAL, PATHOGENIC AND ANATOMOPATHOLOGIC CONSIDERATIONS]. 1963 Arch Argent Tisiol Neumonol pmid:14126674
TAMBIEV AKh and BULGAKOVA VG [THE EFFECT OF INACTIVATION ON THE PROTECTIVE PROPERTIES OF CERTAIN ANTIBIOTICS]. 1963 Radiobiologiia pmid:14068191
PHILES D [ON A CASE OF SURGICALLY TREATED CYSTIC FORMATION OF THE LUNG, PROBABLY OF STAPHYLOCOCCAL ETIOLOGY]. 1963 Hell Iatr pmid:14084759
SUTHERLAND JM OBSERVATIONS ON RELATIONSHIPS BETWEEN DRUG THERAPY AND NEONATAL JAUNDICE. 1963 Ann. N. Y. Acad. Sci. pmid:14085870
SUYAMA T and OGURO Y [STUDIES ON THE SYNERGISTIC EFFECT OF VARIOUS CHEMOTHERAPEUTIC AGENTS AND HUMAN GAMMA GLOBULIN. 1. EXPERIMENTS IN USE WITH PNEUMOCOCCAL INFECTIONS IN MICE]. 1963 J Antibiot B pmid:14086071
COTTIN S [TREATMENT OF STAPHYLOCOCCAL INFECTIONS IN ADULTS]. 1963 Presse Med pmid:14103046
JESKE J et al. [AN INVESTIGATION INTO SOME PHARMACODYNAMIC PROPERTIES OF ERYTHROMYCINUM BASICUM]. 1963 Ann Univ Mariae Curie Sklodowska Med pmid:14232847